Study on the value of human papillomavirus (HPV) load, STMN1 and P16 in the diagnosis and prognosis of cervical lesions

Study on the value of human papillomavirus (HPV) load, STMN1 and P16INK4A in the diagnosis of cervical lesions

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025679

Enrollment

Unknown

Registered

2019-09-05

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Lesions

Interventions

Gold Standard:Cervical pathology results

Index test:human&#32

papillomavirus&#32

(HPV)&#32

load,&#32

STMN1&#32

and&#32

P16

Eligibility

Sex/Gender

Female

Age

21 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. First cervical cancer screening; 2. Aged 21 years and older; 3. Previous sexual life history; 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Women during pregnancy or 6 months after childbirth; 2. Patients with previous cervical lesions; 3. Those who have previously undergone cervical-related surgery.

Design outcomes

Primary

Measure	Time frame
HPV viral load;P16INK4A;STMN1;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactBinhua Dong

Fujian Provincial Maternity and Children's Hospital

dbh18-jy@126.com+86 0591 87558732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026